Prediction of incident neurocognitive impairment by plasma HIV RNA and CD4 levels early after HIV seroconversion

Archives of Neurology

Volumn 60, Issue 10, 2003, Pages 1406-1412

  Marcotte, Thomas D ^a   Deutsch, Reena ^b   McCutchan, J Allen ^c   Moore, David J ^a   Letendre, Scott ^c   Ellis, Ronald J ^d   Wallace, Mark R ^e   Heaton, Robert K ^a   Grant, Igor ^a,f  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^f VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; VIRUS RNA;

ADULT; ARTICLE; CEREBROSPINAL FLUID; COGNITIVE DEFECT; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPETENCE; KAPLAN MEIER METHOD; MAJOR CLINICAL STUDY; MALE; PREDICTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROCONVERSION; T LYMPHOCYTE SUBPOPULATION; VIRUS REPLICATION;

ADULT; CD4 LYMPHOCYTE COUNT; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HIV INFECTIONS; HIV SEROPOSITIVITY; HUMANS; MALE; PREDICTIVE VALUE OF TESTS; RNA, VIRAL;

EID: 0141924452     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.60.10.1406     Document Type: Article

References (44)

1. Heaton RK, Grant I, Butters N, et al. The HNRC 500-Neuropsychology of HIV infection at different disease stages. J Int Neuropsychol Soc. 1995;1:231-251.
2. McArthur JC, Hoover DR, Bacellar H, et al. Dementia in AIDS patients: incidence and risk factors. Neurology. 1993;43:2245-2252
3. McArthur JC, Grant I. HIV neurocognitive disorders. In: Gendelman HE, Lipton S, Epstein L, Swindells S, ed. Neurology of AIDS. New York, NY: Chapman & Hall; 1998:499-524.
4. Bornstein RA, Nasrallah HA, Para MF, et al. Neuropsychological performance in asymptomatic HIV infection. J Neuropsychiatry Clin Neurosci. 1992;4:386-394.
5. Miller EN, Selnes OA, McArthur JC, et al. Neuropsychological performance in HIV-1 infected homosexual men: the Multicenter AIDS Cohort Study (MACS). Neurology. 1990;40:197-203.
6. Stern Y, McDermott MP, Albert S, et al. Factors associated with incident human immunodeficiency virus-dementia. Arch Neurol. 2001;58:473-479.
7. Stern Y, Marder K, Bell K, et al. Multidisciplinary baseline assessment of homosexual men with and without human immunodeficiency virus infection, III: neurologic and neuropsychological findings. Arch Gen Psychiatry. 1991;48:131-138.
8. Bornstein RA, Nasrallah HA, Para MF, Fass RJ, Whitacre CC, Rice RR Jr. Rate of CD4 decline and neuropsychological performance in HIV infection. Arch Neurol. 1991;48:704-707.
9. Childs EA, Lyles RH, Selnes OA, et al. Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy. Neurology. 1999;52:607-613.
10. Ellis RJ, Hsia K, Spector SA, et al. Cerebrospinal fluid human immunodeficiency virus type 1 RNA levels are elevated in neurocognitively impaired individuals with acquired immunodeficiency syndrome. Ann Neurol. 1997;42:679-688.
11. McArthur JC, McClernon DR, Cronin MF, et al. Relationship between human immunodeficiency virus-associated dementia and viral load in cerebrospinal fluid and brain. Ann Neurol. 1997;42:689-698.
12. White DA, Heaton RK, Monsch AU. Neuropsychological studies of asymptomatic human immunodeficiency virus-type 1-infected individuals. J Int Neuropsychol Soc. 1995;1:304-315.
13. Albert SM, Marder K, Dooneief G, et al. Neuropsychologic impairment in early HIV infection: a risk factor for work disability. Arch Neurol. 1995;52:525-530.
14. Heaton RK, Velin RA, McCutchan JA, et al, HNRC Group. Neuropsychological impairment in human immunodeficiency virus-infection: implications for employment. Psychosom Med. 1994;56:8-17.
15. Marcotte TD, Heaton RK, Wolfson T, et al. The impact of HIV-related neuropsychological dysfunction on driving behavior. J Int Neuropsychol Soc. 1999;5:579-592.
16. Ellis RJ, Deutsch R, Heaton RK, et al. Neurocognitive impairment is an independent risk factor for death in HIV infection. Arch Neurol. 1997;54:416-424
17. Mayeux R, Stern Y, Tang M-X, et al. Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment. Neurology. 1993;43:176-182.
18. Centers for Disease Control and Prevention. 1993 Revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992;41(RR-17):1-19.
19. Munoz A, Carey V, Taylor JM, et al. Estimation of time since exposure for a prevalent cohort. Stat Med. 1992;11:939-952.
20. + lymphocyte end-points and AIDS in cohorts of homosexual men. AIDS. 1993;7:1325-1329.
21. Brettle RP, McNeil AJ, Burns S, et al. Progression of HIV: follow-up of Edinburgh injecting drug users with narrow seroconversion intervals in 1983-1985. AIDS. 1996;10:419-430.
22. Grant I, Atkinson JH. Psychiatric aspects of acquired immune deficiency syndrome. In: Kaplan HI, Sadock BJ, eds. Comprehensive Textbook of Psychiatry/ VI, Vol 2. Baltimore, Md: Williams & Wilkins; 1995:1644-1669.
23. American Academy of Neurology AIDS Task Force. Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Neurology. 1991;41:778-785.
24. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457-481.
25. Cox DR, Oakes D. Analysis of Survival Data. New York, NY: Chapman & Hall; 1984.
26. S-Plus 2000 Professional Release 2. Seattle, Wash: MathSoft Inc; 1999.
27. SAS Institute Inc. JMP Statistics and Graphics Guide, Version 3.1. Cary, NC: SAS Institute Inc; 2001.
28. Jurriaans S, Van Gemen B, Weverling GJ, et al. The natural history of HIV-1 infection: virus load and virus phenotype independent determinants of clinical course? Virology. 1994;204:223-233.
29. Phillips AN, Lee CA, Elford J, et al. Serial CD4 lymphocyte counts and development of AIDS. Lancet. 1991;337:389-392.
30. Saykin AJ, Janssen RS, Sprehn GC, Kaplan JE, Spira TJ, Weller P. Neuropsychological dysfunction in HIV-infection: characterization in a lymphadenopathy cohort. Int J Clin Neuropsychol. 1988;10:81-95.
31. Boccellari AA, Chambers DB, Dilley JW, et al. Relationship of β 2 microglobulin and CD4 counts to neuropsychological performance in HIV-1-infected intravenous drug users. J Acquir Immune Defic Syndr. 1994;7:1040-1049.
32. + lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med. 1997;126:946-954.
33. Coffin JM. HIV viral dynamics. AIDS. 1996;10(suppl 3):S75-S84.
34. Ellis RJ, Moore DJ, Childers ME, et al. Progression to neuropsychological impairment in human immunodeficiency virus infection predicted by elevated cerebrospinal fluid levels of human immunodeficiency virus RNA. Arch Neurol. 2002; 59:923-928.
35. Sacktor N, Lyles RH, Skolasky R, et al. HIV-associated neurologic disease incidence changes: Multicenter AIDS Cohort Study, 1990-1998. Neurology. 2001; 56:257-260.
36. Deutsch R, Ellis RJ, McCutchan JA, Marcotte TD, Letendre S, Grant I. AIDS-associated mild neurocognitive impairment is delayed in the era of highly active antiretroviral therapy. AIDS. 2001;15:1898-1899.
37. Letendre S, Ellis RJ, Rippeth J, McCutchan JA. Reduction of CSF RNA levels correlates with reversal of HIV-induced cognitive dysfunction [abstract]. J Neurovirol. 2000;6:246.
38. Dore GJ, Correll PK, Li Y, Kaldor JM, Cooper DA, Brew BJ. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS. 1999;13: 1249-1253.
39. Masliah E, DeTeresa RM, Mallory ME, Hansen LA. Changes in pathological findings at autopsy in AIDS cases for the last 15 years. AIDS. 2000;14:69-74.
40. Neuenburg JK, Brodt HR, Herndier BG, et al. HIV-related neuropathology, 1985 to 1999: rising prevalence of HIV encephalopathy in the era of highly active antiretroviral therapy. J Acquir Immune Defic Syndr. 2002;31:171-177.
41. Sacktor N, McDermott MP, Marder K, et al. HIV-associated cognitive impairment before and after the advent of combination therapy. J Neurovirol. 2002;8: 136-142.
42. McClernon DR, Lanier R, Gartner S, et al. HIV in the brain: RNA levels and patterns of zidovudine resistance. Neurology. 2001;57:1396-1401.
43. Masliah E, Heaton RK, Marcotte TD, et al. Dendritic injury is a pathologic substrate for HIV-related cognitive disorders. Ann Neurol. 1997;42:963-972.
44. Cherner M, Masliah E, Ellis RJ, et al. Neurocognitive dysfunction predicts postmortem findings of HIV encephalitis. Neurology. 2002;59:1563-1567.